Florence Le Maulf

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.6K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis

Sam Schulman, Ajay K. Kakkar, Samuel Z. Goldhaber et al. · Circulation · 2013 · 932 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease

Kevin M. Brown, Athol U. Wells, Emmanuelle Clerisme-Beaty et al. · BMJ Open Respiratory Research · 2017 · 187 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria

Ganesh Raghu, Athol U. Wells, Andrew G. Nicholson et al. · American Journal of Respiratory and Critical Care Medicine · 2016 · 181 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis

Luca Richeldi, Vincent Cottin, Martin Kolb et al. · Respiratory Medicine · 2014 · 103 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13